Breast cancer breakthrough: fewer drugs after surgery may be enough for some patients
NCT ID NCT03716180
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 35 times
Summary
This study tests a new approach for people with HER2-positive breast cancer. If the tumor disappears completely after a short course of chemotherapy and targeted drugs before surgery, patients may only need two antibody drugs after surgery instead of more chemotherapy. The goal is to see if this gentler plan works and is safe. About 100 adults with stage II or III breast cancer are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
DF/BWCC at Milford Regional Medical Center
Milford, Massachusetts, 01757, United States
-
DF/BWCC in clinical affiliation with South Shore Hospital
South Weymouth, Massachusetts, 02190, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.